SELECTBIO Conferences High-Content and Phenotypic Screening Europe 2018
High-Content and Phenotypic Screening Europe 2018
Date: May 24 - 25, 2018
Venue: Cambridge, UK

Keynote Speakers

Paul French

Paul French
Professor, Department of Physics and Photonics Group, Imperial College London

Matthew Daniels

Matthew Daniels
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist, University of Oxford

Stefan Dubel

Stefan Dubel
Full Professor and Director, Technische Universitat Braunschweig

Stephen Helliwell

Stephen Helliwell
Senior Investigator, Novartis Institutes for BioMedical Research

Robert Williams

Robert Williams
Chief Drug Development Scientist, Cancer Research UK

Gary Gintant

Gary Gintant
Research Fellow, Abbvie

David Hay

David Hay
Professor, University of Edinburgh


High-Content & Phenotypic Screening 2018 is part of Select Biosciences Innovations in Drug Discovery 2018 Conference Series to be held in Cambridge, UK.

This conference held co-located and concurrently with Stem Cells in Drug Discovery 2018 and Antibodies in Drug Discovery 2018 explores the emerging trends and technologies impacting Drug Discovery, circa 2018.

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High-Content technologies and Phenotypic Screening applications.

Hot topics to be covered include 3D-cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and technology/tools vendors, helping you to find solutions and build collaborations.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 14 May 2018

Agenda Topics

  • High-Content Analysis and Phenotypic Screening for New Targets
  • Image Analysis and Data Management Tools
  • Phenotypic and High Content Screening of 3D-Model Systems
  • Phenotypic Drug Discovery

Confirmed Speakers to date

Louise Affleck, UK Team Leader, Cisbio Bioassays
Ofer Binah, Professor, Department of Physiology, Biophysics and Systems Biology, Ruth & Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology
Hugh Byrne, Professor, Dublin Institute of Technology
Jacqueline Chuah, Lab Officer, Institute of Bioengineering and Nanotechnology, A*Star
Nicholas Hannan, Assistant Professor, University of Nottingham
Ben Haworth, Cellular Imaging Application Specialist, GE Life Sciences
Peter Horvath, Finnish Distinguished Professor, Fellow FIMM Helsinki and Group Leader, Hungarian Academia of Sciences
Simon Hufton, Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC)
Hua Rong Lu, Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV
Peter O'Brien, Head of Clinical Pathology, University College Dublin
Alice Pebay, Associate Professor, Principal Research Fellow, University of Melbourne & Centre for Eye Research Australia
Sanjay Sinha, BHF Senior Research Fellow, University of Cambridge
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
E. Sally Ward, Professor, Texas A&M University Health Science Center
Joanne Young, Senior Scientist, CYTOO SA

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Traditional Chinese
Simplified Chinese